Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...
CL stock, with 12% returns since the beginning of 2024, has underperformed the S&P 500 index, up 27%. The strengthening of ...
Colgate-Palmolive (NYSE:CL – Get Free Report) has received an average rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the company, Ratings reports. One research ...
X added seven companies to its lawsuit Saturday, alleging they partook in a World Federation of Advertisers-coordinated (WFA) ...
Toothpaste maker Colgate-Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales ...
Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
This, in turn, made X "a less effective competitor to other social media platforms in the sale of digital advertising and in ...
Colgate-Palmolive CEO Noel Wallace highlighted intense discounting wars among consumer goods companies in India due to ...
Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.